Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Robbins

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Carbohydrate Research|May 24, 2011
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme diseaseVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
The Journal of Organic Chemistry|June 21, 2012
Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigensVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Vaccine|June 10, 2008
Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugatesJoanna Kubler-Kielb, Evgeny Vinogradov, Gil Ben-Menachem, et al.
Infection and Immunity|July 25, 2006
Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugatesJoanna Kubler-Kielb, Teh-Yung Liu, Christopher Mocca, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine componentJoanna Kubler-Kielb, Evgeny Vinogradov, Haijing Hu, et al.
Vaccine|September 3, 2013
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experienceBirgit Thierry-Carstensen, Tine Dalby, Michael A Stevner, et al.
Carbohydrate Research|February 7, 2006
Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugatesAnikó Fekete, Peter Hoogerhout, Gijsbert Zomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2John B Robbins, Rachel Schneerson, Guilin Xie, et al.
Carbohydrate Research|June 15, 2010
Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidatesJoanna Kubler-Kielb, Evgeny Vinogradov, Christopher Mocca, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Carbohydrate Research|May 24, 2011
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme diseaseVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
The Journal of Organic Chemistry|June 21, 2012
Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigensVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Vaccine|June 10, 2008
Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugatesJoanna Kubler-Kielb, Evgeny Vinogradov, Gil Ben-Menachem, et al.
Infection and Immunity|July 25, 2006
Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugatesJoanna Kubler-Kielb, Teh-Yung Liu, Christopher Mocca, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine componentJoanna Kubler-Kielb, Evgeny Vinogradov, Haijing Hu, et al.
Vaccine|September 3, 2013
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experienceBirgit Thierry-Carstensen, Tine Dalby, Michael A Stevner, et al.
Carbohydrate Research|February 7, 2006
Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugatesAnikó Fekete, Peter Hoogerhout, Gijsbert Zomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2John B Robbins, Rachel Schneerson, Guilin Xie, et al.
Carbohydrate Research|June 15, 2010
Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidatesJoanna Kubler-Kielb, Evgeny Vinogradov, Christopher Mocca, et al.
Pageof 6